The role of azithromycin after lung transplantation

G. Verleden (Leuven, Belgium)

Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Session: Non-antibiotic effects of macrolides in lung disease
Session type: Symposium
Number: 3069

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Verleden (Leuven, Belgium). The role of azithromycin after lung transplantation. Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Azithromycin treatment in patients with BOS after lung transplantation
Source: ISSN=ISSN 1810-6838, ISBN=, page=178
Year: 2005

Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 174s
Year: 2007

Lymphocytic bronchiolitis after lung transplantation: a role for azithromycin?
Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options
Year: 2009



Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Year: 2003


Mortality after lung transplantation (LTx): The emerging role of solid organ tumors
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

CF lung disease and lung transplantation
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

CF lung disease and lung transplantation
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

CF lung disease and lung transplantation
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

CT findings before and after azithromycin treatment of chronic lung allograft dysfunction
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011

Infectious complications after lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193
Year: 2003

Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007


Paediatric lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=243
Year: 2003

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



Paediatric lung transplantation
Source: Eur Respir J 2004; 24 : 839-845
Year: 2004



Inhaled colistin following lung transplantation in colonised cystic fibrosis patients
Source: Eur Respir J 2013; 42: 542-544
Year: 2013


The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012

Pre-habilitation in lung transplant candidates
Source: Short video discussion 2021
Year: 2021

Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008